Among patients with squamous cell carcinomas of oral cavity and oropharynx, the proportion of cancers with tumor STING immunoexpression (TSI) was significantly higher in patients with regression of disease than that in patients with progression of disease (54). This evidence concerns the gene STING1 and cancer.